Descoberta de Drogas; Proteínas de Membrana/metabolismo; Ressonância de Plasmônio de Superfície/métodos; Ligantes; Ligação Proteica; Receptores Acoplados a Proteínas G/metabolismo

1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; 3-[(3-Cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate; ABC; ADP; AMP; AMPPNP; ATP; ATP binding cassette; Adenosine-5'-(ß,γ-imido)triphosphate; Adenosine-5'-diphosphate; Adenosine-5'-monophosphate; Adenosine-5'-triphosphate; BACE1; BPM; Biophysical Mapping; CHAPSO; CMC; Critical micelle concentration; DDM; Drug discovery; EGF; EOT; Epidermal growth factor; Extraordinary optical transmission; G protein-coupled receptor; GABA; GDP; GPCR; GTP; Guanosine-5'-diphosphate; Guanosine-5'-triphosphate; HPA; HTA; Human (pro)renin receptor; Human olfactory receptor 17-4; Hydrophobic association (sensor chip); Kinetics; Ligand binding; MSP; Membrane protein; Membrane scaffold protein; N-Y4; NPY; Neuropeptide Y; Neuropeptide Y4; PDB; POPC; PP; PYY; Pancreatic polypeptide; Polypeptide YY; Protein Data Bank; RU; Resonance or response units; SAM; SDF-1α; SLB; SPR; SPRM; Self-assembled monolayer; Sensors; StaR; Stabilised receptor; Stromal cell-derived factor 1α; Supported lipid bilayer; Surface plasmon resonance; Surface plasmon resonance microscopy; hOR17-4; hPRR; n-Dodecyl-ß-d-maltoside; ß-Site amyloid precursor protein cleaving enzyme 1; γ-Aminobutyric acid type A (receptors); ω-Hydroxy-undecanethiol